| Arc Mental Health | |
|
14400 Nw 77th Ct Ste 100 Miami Lakes FL 33016-1590 | |
| (786) 916-6073 | |
| (786) 657-3092 |
| Full Name | Arc Mental Health |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 14400 Nw 77th Ct Ste 100, Miami Lakes, Florida |
| Authorized Official Name and Position | Michelle T Reichard (CEO) |
| Authorized Official Contact | 7874573777 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Arc Mental Health 14400 Nw 77th Ct Ste 100 Miami Lakes FL 33016-1590 Ph: (786) 916-6073 | Arc Mental Health 14400 Nw 77th Ct Ste 100 Miami Lakes FL 33016-1590 Ph: (786) 916-6073 |
| NPI Number | 1982102901 |
|---|---|
| Provider Enumeration Date | 01/24/2018 |
| Last Update Date | 08/17/2022 |
| Certification Date | 08/17/2022 |
| Medicare PECOS PAC ID | 8921425158 |
|---|---|
| Medicare Enrollment ID | O20200902000577 |
News Archive
Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982102901 | NPI | - | NPPES |
| 104616600 | Medicaid | FL | |
| 107662100 | Medicaid | FL |
| Provider Name | Ileana D Dominguez Baute |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1659907178 PECOS PAC ID: 1254757644 Enrollment ID: I20200817000631 |
News Archive
Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 3 days ago
| Provider Name | Luis Manuel Gomez Hernandez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063043164 PECOS PAC ID: 7719399500 Enrollment ID: I20201221000937 |
News Archive
Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 3 days ago
| Provider Name | Jason Lopez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1659802916 PECOS PAC ID: 9335549518 Enrollment ID: I20210609001412 |
News Archive
Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 3 days ago
| Provider Name | Ibis Reyes Soto |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548804164 PECOS PAC ID: 3476954603 Enrollment ID: I20210625001222 |
News Archive
Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 3 days ago
| Provider Name | Michelle Reichard Stubbe |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1003450289 PECOS PAC ID: 8820415052 Enrollment ID: I20231130000156 |
News Archive
Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 3 days ago
News Archive
Troublesome dyspnea that limits sexual activity is common among older patients with COPD, according to a new study from Denmark.
Using a combination of a targeted cancer-fighting agent called DFMO and a low dose of an anti-inflammatory drug, UC Irvine researchers have reduced the risk of reoccurring colorectal polyps, an early sign of colon cancer, by as much as 95 percent with fewer toxic side effects.
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 3 days ago
Permuy Diversity Interventions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8760 Nw 146th Ln, Miami Lakes, FL 33018 Phone: 786-238-5931 | |
Productive Minds Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6625 Miami Lakes Dr, Miami Lakes, FL 33014 Phone: 305-998-9806 | |
Jcv Behavior Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6625 Miami Lakes Dr Ste 226, Miami Lakes, FL 33014 Phone: 305-777-3884 Fax: 305-777-3885 | |
Limitless Growth Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14100 Palmetto Frntg Rd Ste 112, Miami Lakes, FL 33016 Phone: 786-837-3540 | |
Children Behavioral Therapy Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7779 Nw 146th St, Miami Lakes, FL 33016 Phone: 786-702-6868 | |
Bosc Mental Health, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15233 Nw 87th Ct, Miami Lakes, FL 33018 Phone: 786-643-3835 Fax: 305-470-7457 | |
Second Chance Case Management Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15485 Eagle Nest Ln Ste 150, Miami Lakes, FL 33014 Phone: 178-302-5424 Fax: 786-396-5317 |